At the White House’s Invitation, NACDS Participates in Bill Signing Ceremony for “Gag Clause” Prohibition NACDS applauds Trump Administration’s focus on reducing patients’ out-of-pocket prescription drug costs, and Congressional sponsors’ effectiveness in advancing legislation

2018-10-10T14:30:40+00:00Oct-10-18|Categories: Press Release|Tags: , , |

NACDS applauded the Trump Administration’s focus on reducing patients’ out-of-pocket drug costs, and Congressional sponsors’ effectiveness in advancing the "gag clause" ban. NACDS noted that pharmacy is a long-standing and trusted partner in helping patients achieve prescription-drug affordability – which is essential for health and wellness.

U.S. Senate Passes NACDS Policy Recommendations in Opioid Bill Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse

2018-10-03T15:58:33+00:00Oct-03-18|Categories: Press Release|Tags: , |

Legislation headed to President’s desk bears pharmacists’ insights from front lines of care, reflects pharmacy’s commitment as part of the solution to abuse.

House Sends NACDS-Backed “Gag Clause” Prohibition to President Legislation prevents restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance;NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs

2018-09-25T17:03:37+00:00Sep-25-18|Categories: Press Release|Tags: , , |

The legislation will prevent restrictions on pharmacists’ ability to tell patients when they can save money on prescriptions by paying cash instead of using insurance. Meanwhile, NACDS positions DIR fee reform as another crucial issue for lowering out-of-pocket drug costs.

Load More Posts